Today: 27 June 2026
S&P Global stock edges up after hours ahead of earnings — what SPGI investors are watching
10 February 2026
1 min read

S&P Global stock edges up after hours ahead of earnings — what SPGI investors are watching

New York, Feb 9, 2026, 19:10 EST — After-hours

  • S&P Global picked up 1.1% during the regular session, then tacked on another 0.4% after hours.
  • Quarterly results land Tuesday, and investors are zeroed in on guidance plus the Mobility separation.
  • U.S. stocks finished in positive territory, with investors eyeing major economic reports expected later this week.

S&P Global Inc caught a bid after the bell on Monday, adding to earlier session strength as traders positioned ahead of the data and ratings giant’s upcoming quarterly results, set for Tuesday.

This shift comes after the stock took some hits in recent sessions. The upcoming update stands out as an early test for market-data and ratings companies this earnings season. If debt issuance shows signs of life, ratings fees could get a lift; if things stay quiet, fee growth could stall.

It comes as markets remain on edge. U.S. stocks finished up Monday. Still, investors are watching for fresh U.S. inflation and employment data—numbers that could quickly swing rate bets and shake up risk taking.

S&P Global gained 1.1%, wrapping up the session at $444.19. After hours, shares were last seen trading near $445.85. U.S. markets officially close at 4 p.m., but activity often extends beyond that.

Wall Street is looking for revenue to land near $3.90 billion and adjusted earnings of $4.33 per share, according to a StockStory note cited by Barchart, with shares off about 19% in the past month. A few rivals have already stepped up with results—Nasdaq delivered double-digit revenue growth, while Intercontinental Exchange beat forecasts too, the note pointed out.

The other angle: S&P Global is moving ahead with plans to spin off its Mobility unit. Last week, the company introduced “Mobility Global” as the future name for the standalone business. Mobility President Bill Eager, in the rollout, described it as “the world’s standard for automotive intelligence.” News Release Archive

Investors want to know how fast the split shifts from a branding story to nuts and bolts—timing, costs, and the shape of S&P Global after spinning off its automotive-data arm.

Everything still comes down to the core Ratings business. Revenue rises and falls with bond issuance—more deals mean more demand for ratings. Even so, turbulence in credit markets can suddenly bring activity to a standstill. If that happens, even solid subscription income from other lines probably won’t make up for a soft quarter here.

Execution comes with its own set of risks. Spinning off a unit can pull management’s attention away from day-to-day operations. Slip up on regulatory filings or disclosures, and the resulting uncertainty drags on—leaving the multiple under strain.

The next big trigger is just ahead. S&P Global will post its fourth-quarter and 2025 full-year numbers around 7:15 a.m. ET on Tuesday, the company confirmed. The earnings call kicks off at 8:30 a.m.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Nvidia Invests in AI-Driven Biotechnology Firm Generate Biomedicines, Targeting $1.8 Trillion Pharma Market
    June 27, 2026, 9:17 AM EDT. Nvidia (NASDAQ: NVDA) has acquired 833,325 shares in Generate Biomedicines (NASDAQ: GENB), a $2 billion market cap biotechnology company using AI to digitally test drug molecules. This minority stake reflects Nvidia's confidence in GENB's AI platform, which accelerates drug discovery by simulating molecule performance before costly clinical trials. Generate's pipeline includes four drug candidates, with one in phase 3 testing for severe asthma. Nvidia's venture capital arm NVentures' $13 million investment aligns with the tech giant's expertise in AI hardware, highlighting the growing convergence of AI and biopharma. The move positions Generate Biomedicines to potentially disrupt the $1.8 trillion pharmaceutical market by reducing drug development time and costs, addressing key industry challenges.

Latest articles

Oil Prices Today: Brent Whipsaws as Iran Peace Hopes Hit OPEC Supply Shock

Funds trim WTI longs, Hormuz supply flows ease squeeze from tight U.S. stocks

27 June 2026
Brent crude plunged 10.86% this week to $71.99 as funds slashed net long WTI positions by 13,356 contracts, despite Cushing inventories hitting their lowest since 2014 and U.S. diesel margins surging; investors face key risks from Hormuz traffic, U.S.-Iran tensions, OPEC+ output hikes, and China’s fuel export boost.
AI stocks eye $41 billion tech-fund shift as memory costs hit

AI stocks eye $41 billion tech-fund shift as memory costs hit

27 June 2026
Technology sector funds saw nearly $20 billion in outflows the week to June 24—erasing the prior week’s $21.46 billion inflows—just before chip stocks plunged, with the Nasdaq dropping 4.6% and the Philadelphia semiconductor index posting its worst week since April, as investors questioned AI profitability and shifted away from tech.
IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

27 June 2026
Bending Spoons (NASDAQ:BSP) drives 61% of next week’s $2.56 billion U.S. IPO proceeds, making its $1.57 billion raise a key test for investor appetite in debt-heavy software M&A, with a $18.1 billion valuation and 4.0x net debt to EBITDA leverage, as markets brace for a holiday-shortened week and a looming $29.4 billion SK hynix Nasdaq ADR.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop